JUMPCAN(SH:600566)2015-04-27 16:00Financial Performance - Net profit attributable to shareholders rose by 27.08% to CNY 159,628,820.20 year-on-year[7] - Operating revenue grew by 26.86% to CNY 904,464,742.13 compared to the same period last year[7] - The company's net profit for Q1 2015 was CNY 158,500,990.32, an increase of 26.2% compared to CNY 125,612,957.33 in the same period last year[32] - The total profit for Q1 2015 reached CNY 184,780,762.89, an increase of 26.4% from CNY 146,220,161.22 in the same quarter last year[32] - Basic and diluted earnings per share for Q1 2015 were both CNY 0.204, up from CNY 0.163, indicating a 25.2% increase[33] - The total comprehensive income for Q1 2015 was CNY 158,500,990.32, up from CNY 125,612,957.33, indicating a growth of 26.2%[33] Asset and Liability Changes - Total assets increased by 6.93% to CNY 3,590,549,454 compared to the end of the previous year[7] - Total liabilities rose to ¥1,413,297,420.29 from ¥1,063,721,441.23, indicating a significant increase of 32.9%[25] - Non-current assets totaled ¥1,666,625,666.37 at the end of Q1 2015, compared to ¥1,379,542,466.87 at the beginning of the year, marking an increase of 20.8%[24] - Total current assets amounted to CNY 1,923,923,787.63, a decrease from CNY 1,978,173,523.11 at the beginning of the year, reflecting a decline of approximately 2.73%[23] Cash Flow and Investment - Net cash flow from operating activities decreased by 20.72% to CNY 174,820,736.83[7] - Cash inflow from operating activities totaled CNY 982,961,146.93, compared to CNY 783,124,729.57, reflecting a growth of 25.5%[36] - Investment activities generated a net cash flow of -¥252,615,144.50, compared to -¥29,723,253.94 in Q1 2014, indicating a significant increase in cash outflow[37] - Financing activities resulted in a net cash flow of -¥41,511,988.90, a decrease from a positive net cash flow of ¥411,866,283.41 in the previous year[37] Shareholder and Ownership Information - The number of shareholders reached 13,916 at the end of the reporting period[10] - The largest shareholder, Jiangsu Jichuan Holding Group Co., Ltd., holds 66.13% of the shares[10] Operational Independence and Compliance - The company reported a commitment to maintain independent operations and avoid any competitive conflicts with its subsidiaries[21] - The company has pledged to respect its independent legal status and ensure autonomous decision-making in its operations[21] - The company guarantees that key management personnel will not hold positions in other controlled enterprises, ensuring operational independence[19] - The company is focused on compliance with legal and regulatory requirements to prevent any misuse of the listed company's assets[19] Changes in Expenses and Costs - Management expenses increased by 61.46% to ¥77,916,961.91 driven by increased R&D investments and additional subsidiaries[14] - Total operating costs for Q1 2015 were ¥747,854,665.22, up from ¥588,815,388.64, reflecting a year-over-year increase of 27%[31] - Cash paid for purchasing goods and services rose by 73.54% to ¥131,784,577.18 reflecting higher raw material costs[15] Investment and Acquisitions - The company completed the acquisition of 100% equity in Dongke Pharmaceutical, with 70% equity registration completed[16] - Investment income surged by 5688.76% to ¥3,528,767.12 due to increased returns from idle fundraising[14] - Cash received from investment recovery increased by 5500.00% to ¥280,000,000.00 due to higher returns from idle fundraising[15] Changes in Receivables and Payables - Accounts receivable increased by 81.89% to CNY 28,494,902.50 due to an increase in payments settled by notes[12] - Other receivables increased by 144.42% to ¥5,437,009.57 due to increased travel advances[13] - Other payables increased to ¥457,270,199.65 from ¥399,875,924.13, reflecting a rise of 14.3%[24]